About Dabur Chyawanprash
Dabur Chyawanprash is a Healthcare company. Ayurvedic formulations for immunity and health support. The company has 5,716 employees. Its Indian entity Dabur India Limited reported revenue of ₹13,792 Cr. Dabur Chyawanprash offers products and services including Chyawanprash and Chyawanprakash Tablets. Its focus areas include Health and Wellness, Nutraceuticals, Health Foods and Jams and Spreads.
Company details
Dabur Chyawanprash is prepared as an Ayurvedic formulation consisting of over 41 herbs, which is designed to enhance the immune system and protect against everyday infections like cough and cold. It is utilized by individuals across all age groups, with benefits including blood purification, support for heart and respiratory health, and improved digestion. The product is derived from traditional recipes aimed at restoring vitality, as evidenced by clinical testing, and is consumed to normalize blood pressure and promote overall strength. Its role in nourishing mucous membranes and revitalizing skin cells is also noted.
- Employees 5,716
- SectorsHealthcare
- Website daburchyawanprash.com
- Social Facebook Instagram YouTube
- Legal Name Dabur India Limited
- Date of Incorporation 16 Sep, 1975
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹13,792 Cr
FY 2026 · +5% YoY
- Indian entity net profit₹1,888 Cr
FY 2026 · 14% margin
- Indian entity EBITDA₹2,435 Cr
FY 2026 · 18% margin
- Employee Count5,716
Associated legal entities of Dabur Chyawanprash
Dabur Chyawanprash operates through Dabur India Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dabur India Limited Listed CIN L24230DL1975PLC007908 | Active | 16 Sep 1975 | New Delhi, Delhi | ₹13,792 Cr | 5,738 | 15 | View details |
Products & Services of Dabur Chyawanprash
Dabur Chyawanprash offers a comprehensive portfolio of products and services, including Chyawanprash and Chyawanprakash Tablets.
It is prepared as an Ayurvedic formulation to boost immunity and support overall health across various age groups.
These tablets are developed to aid in immunity enhancement and are offered as an alternative form of the formulation.
Apps and channels of Dabur Chyawanprash
its YouTube channel Dabur Chyawanprash has 10.4K subscribers and 30 videos.
Videos from Dabur Chyawanprash
The most watched videos on Dabur Chyawanprash's YouTube channel, Dabur Chyawanprash (10.4K subscribers). Click a video to play it here.
More on Dabur Chyawanprash.
Board of directors of Dabur India Limited (Dabur Chyawanprash)
Dabur India Limited is the primary company behind Dabur Chyawanprash. The board of Dabur India Limited currently have 12 directors; the longest-serving is Pritam Das Narang, appointed in 1998. 21 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pritam Das Narang DIN 00021581 | Whole-time director | 01 Apr 1998 | 28 yrs 7 mo | Dabur India Limited |
| Amit Burman DIN 00042050 | Director | 01 Nov 2001 | 25 yrs | Dabur India Limited |
| Mohit Burman DIN 00021963 | Director | 23 Jul 2007 | 19 yrs 3 mo | Dabur India Limited |
| Saket Burman DIN 05208674 | Director | 31 Jan 2012 | 14 yrs 9 mo | Dabur India Limited |
| Mohit Malhotra DIN 08346826 | Whole-time director | 31 Jan 2019 | 7 yrs 9 mo | Dabur India Limited |
| Ajit Mohan Sharan DIN 02458844 | Director | 31 Jan 2019 | 7 yrs 9 mo | Dabur India Limited |
| Aditya Chand Burman DIN 00042277 | Director | 19 Jul 2019 | 7 yrs 3 mo | Dabur India Limited |
| Mukesh Hari Butani DIN 01452839 | Director | 01 Jan 2021 | 5 yrs 10 mo | Dabur India Limited |
| Rajiv Mehrishi DIN 00208189 | Director | 01 Sep 2021 | 5 yrs 2 mo | Dabur India Limited |
| Satyavati Berera DIN 05002709 | Director | 01 Jun 2023 | 3 yrs 5 mo | Dabur India Limited |
| Romesh Sobti DIN 00031034 | Director | 01 Apr 2024 | 2 yrs 7 mo | Dabur India Limited |
| Ravi Kapoor DIN 00185981 | Director | 25 Jun 2024 | 2 yrs 4 mo | Dabur India Limited |
Financials of Dabur Chyawanprash
Figures of Dabur India Limited, the primary company behind Dabur Chyawanprash, for FY 2026. Revenue was ₹13,792 Cr (+5% year on year). Net profit was ₹1,888 Cr (14% margin). EBITDA was ₹2,435 Cr (18% margin). Revenue has grown at a compounded annual rate of +5% over three years and +7% over five years.
- ₹13,792 CrRevenue · FY 2026 · +5% YoY
- ₹1,888 CrNet profit · 14% margin
- ₹2,435 CrEBITDA · 18% margin
- ₹177 CrPaid-up capital
- 5,738Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Dabur India Limited are on its company page.
Detailed financial statements for Dabur Chyawanprash
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dabur Chyawanprash
Complete news archive for Dabur Chyawanprash
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dabur Chyawanprash
Dabur Chyawanprash has 5,716 employees.
The primary company behind Dabur Chyawanprash, Dabur India Limited, reported revenue of ₹13,792 Cr for FY 2026, up 5% year on year.
Dabur Chyawanprash is prepared as an Ayurvedic formulation consisting of over 41 herbs, which is designed to enhance the immune system and protect against everyday infections like cough and cold. It is utilized by individuals across all age groups, with benefits including blood purification, support for heart and respiratory health, and improved digestion. The product is derived from traditional recipes aimed at restoring vitality, as evidenced by clinical testing, and is consumed to normalize blood pressure and promote overall strength. Its role in nourishing mucous membranes and revitalizing skin cells is also noted.
Dabur Chyawanprash offers Chyawanprash and Chyawanprakash Tablets.
Dabur Chyawanprash operates through Dabur India Limited.
The legal entities of Dabur Chyawanprash currently have 14 directors, including Saket Burman, Pritam Das Narang, Aditya Chand Burman and others.